Chondrocalcinosis

Differentiating chondrocalcinosis (CPPD) from osteoarthritis (OA) on imaging, particularly in the knee, can be challenging as both present with joint pain and cartilage degeneration in elderly patients. Radiographically, chondrocalcinosis is characterized by linear or punctate calcifications within hyaline or fibrocartilage, most commonly in the menisci, triangular fibrocartilage, and articular cartilage. These calcifications, representing calcium pyrophosphate dihydrate (CPPD) crystal deposits, may not always be apparent. Osteoarthritis, on the other hand, primarily demonstrates joint space narrowing, osteophyte formation, and subchondral sclerosis. While both conditions can exhibit subchondral cysts, they are more prevalent in OA. If radiographs are inconclusive, consider utilizing other imaging modalities like ultrasound or MRI. Ultrasound can detect CPPD crystals not visible on x-ray, while MRI offers superior soft tissue contrast, aiding in the assessment of cartilage damage and synovitis, which can accompany CPPD crystal deposition. Explore how advanced imaging techniques can improve diagnostic accuracy in differentiating these conditions.

Managing an acute pseudogout (calcium pyrophosphate dihydrate deposition disease or CPPD) flare in the knee typically involves a combination of pharmacologic and non-pharmacologic strategies. Non-pharmacologic interventions, such as joint rest, ice application, and compression, can provide immediate symptom relief. For mild to moderate pain, consider administering nonsteroidal anti-inflammatory drugs (NSAIDs) as first-line pharmacologic therapy. If NSAIDs are contraindicated or insufficient, intra-articular corticosteroid injections can be highly effective in rapidly reducing inflammation and pain. Colchicine can also be considered, particularly for patients with contraindications to NSAIDs or corticosteroids, although it may take longer to achieve symptomatic relief. Learn more about tailoring treatment strategies based on patient-specific factors and disease severity.

While joint pain is the hallmark of calcium pyrophosphate dihydrate deposition disease (CPPD, also known as pseudogout), clinicians should be vigilant for less common systemic manifestations. CPPD can occasionally mimic other rheumatic diseases, causing a mild inflammatory polyarthritis affecting multiple joints. In rare instances, severe cases can present with features resembling a rapidly destructive arthropathy, mimicking septic arthritis. Extra-articular manifestations are infrequent but can include CPPD crystal deposition in ligaments, tendons, and even cardiac valves. Furthermore, although not fully understood, some studies suggest a possible association between CPPD and metabolic disorders such as hyperparathyroidism, hypomagnesemia, and hemochromatosis. Consider implementing a comprehensive metabolic workup in patients with recurrent or atypical presentations of CPPD. Further research is needed to fully elucidate the complex interplay between CPPD and these systemic conditions.